00945nas a2200349   4500000000100000008004100001260004900042653002200091653001100113653002400124653001700148653001600165653001100181653001700192653002300209653002400232653002500256653000900281653002200290653001600312100001100328700001300339700001400352700001400366700001100380700001600391245010700407856005000514300001000564490000700574022001400581       2011                            d  c2011 SepbLEPRA Health in ActionaColchester10aAntifungal Agents10aBiopsy10aChromoblastomycosis10aCladosporium10aClofazimine10aHumans10aItraconazole10aLeprostatic Agents10aLeprosy, Borderline10aLeprosy, lepromatous10aMale10aTreatment Outcome10aYoung Adult1 aApte G1 aGedam JR1 aPoojary S1 aNagpur NG1 aPai VV1 aGanapathi R00aChromoblastomycosis in a case of borderline lepromatous leprosy with recurrent type II lepra reaction.  uhttps://leprosyreview.org/article/82/3/01-559  a310-50 v82  a0305-7518